Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003229 · ClinicalTrials.gov registry record · Phase 1

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

A Phase 1 study of Melanoma (Skin), sponsored by Duke University.

Completed
Registry status
Phase 1
Development phase
2
Study locations

NCT00003229 is a Phase 1 study of Melanoma (Skin) that has completed, run by Duke University. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003229, a Phase 1 study of Melanoma (Skin), has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 1
Development phase
2
Study locations

Study Summary

RATIONALE: Vaccines made from a person's white blood cells and melanoma cells may make the body build an immune response and kill the tumor cells. PURPOSE: Randomized phase I/II trial to study the effectiveness of vaccine therapy made from white blood cells and melanoma cells in treating patients with metastatic melanoma who are undergoing surgery for lymph node and tumor removal.

Conditions Studied

Melanoma (Skin)

Interventions

  • BIOLOGICAL aldesleukin
  • BIOLOGICAL gp100 antigen
  • BIOLOGICAL tyrosinase peptide

Study Locations (2)

North Carolina

  • Duke Comprehensive Cancer Center - Durham

Virginia

  • Cancer Center, University of Virginia HSC - Charlottesville

Trial Details

FieldValue
Start Date 1997-07
Est. Completion 2005-02
Phase Phase 1

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003229

The ClinicalTrials.gov registry entry for NCT00003229 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 3 interventions - of which aldesleukin is the first listed.

NCT00003229 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.

Frequently Asked Questions

What is clinical trial NCT00003229 about?

NCT00003229 is a clinical study titled "Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal". RATIONALE: Vaccines made from a person's white blood cells and melanoma cells may make the body build an immune response and kill the tumor cells. PURPOSE: Randomized phase I/II trial to study the effectiveness of vaccine therapy made from white blood cells and melanoma cells in treating patients w...

What is the current status of trial NCT00003229?

This trial is currently completed. It is a Phase 1 study. The study started on 1997-07. Estimated completion is 2005-02.

What conditions does trial NCT00003229 study?

This clinical trial studies the following conditions: Melanoma (Skin).

What interventions are being tested in trial NCT00003229?

The interventions under investigation include: aldesleukin (BIOLOGICAL), gp100 antigen (BIOLOGICAL), tyrosinase peptide (BIOLOGICAL).

Who is sponsoring clinical trial NCT00003229?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003229 being conducted?

This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma (Skin)

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.